Related Experiment Videos
Use of a beta-agonist in ventilated, very-low-birth-weight babies: a longitudinal evaluation
S J Kovacs1, J B Fisher, N L Brodsky
1Division of Neonatology, Albert Einstein Medical Center, Philadelphia, Pa.
Insights
Ventilated preterm infants do not show a specific age for responding to beta-agonists. Individual pulmonary function testing is recommended to identify infants who will benefit from these treatments.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Pharmacology
Background:
- Preterm infants often require mechanical ventilation.
- The efficacy of beta-agonists in this population is variable.
- Identifying predictors of response is crucial for optimizing treatment.
Purpose of the Study:
- To investigate if a specific postnatal age (PNA) or postconceptional age (PCA) correlates with beta-agonist response in ventilated preterm infants.
- To assess individual variability in response to albuterol.
Main Methods:
- Evaluated 15 preterm infants (mean GA 26.5 weeks) requiring mechanical ventilation.
- Performed weekly pulmonary function testing (PFT) before and after albuterol administration.
- Utilized regression analysis to examine the relationship between PNA/PCA and response.
Main Results:
- No significant relationship was found between PNA or PCA and beta-agonist response when analyzing the group as a whole.
- Individual infant analysis revealed consistent responders and non-responders.
- Albuterol administration did not show a consistent age-dependent effect.
Conclusions:
- Beta-agonist response in ventilated preterm infants is not age-dependent.
- Individualized pulmonary function testing (PFT) is essential to identify infants likely to benefit from beta-agonists.
- Tailoring treatment based on PFT can improve therapeutic outcomes.
Abstract:
To determine if there is a specific postnatal (PNA) or postconceptional age (PCA) at which ventilated preterm infants respond to beta-agonists, we evaluated 15 infants with a mean gestational age of 26.5 +/- 1.5 weeks and mean birth weight of 0.89 +/- 0.23 kg who required mechanical ventilation at 10 days of age. Weekly pulmonary function testing (PFT) was performed before and 1 h after administration of albuterol. Taking the group as a whole, as well as individual babies, regression analysis showed no relationship between positive response and either PNA or PCA. Evaluation of individual infants, however, showed that some consistently responded to beta-agonists whereas others did not. We recommend individual PFT to identify those infants who will benefit from use of beta-agonists.